Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

Research output: Contribution to journalArticle


title = "Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS",
abstract = "Lenalidomide is a highly effective treatment for myelodysplastic syndrome (MDS) with deletion of chromosome 5q (del(5q)). Here, we demonstrate that lenalidomide induces the ubiquitination of casein kinase 1A1 (CK1α) by the E3 ubiquitin ligase CUL4-RBX1-DDB1-CRBN (known as CRL4CRBN), resulting in CK1α degradation. CK1α is encoded by a gene within the common deleted region for del(5q) MDS and haploinsufficient expression sensitizes cells to lenalidomide therapy, providing a mechanistic basis for the therapeutic window of lenalidomide in del(5q) MDS. We found that mouse cells are resistant to lenalidomide but that changing a single amino acid in mouse Crbn to the corresponding human residue enables lenalidomide-dependent degradation of CK1α. We further demonstrate that minor side chain modifications in thalidomide and a novel analogue, CC-122, can modulate the spectrum of substrates targeted by CRL4CRBN. These findings have implications for the clinical activity of lenalidomide and related compounds, and demonstrate the therapeutic potential of novel modulators of E3 ubiquitin ligases.",
author = "Jan Kr{\"o}nke and Fink, {Emma C.} and Hollenbach, {Paul W.} and MacBeth, {Kyle J.} and Hurst, {Slater N.} and Udeshi, {Namrata D.} and Chamberlain, {Philip P.} and Mani, {D. R.} and Man, {Hon Wah} and Gandhi, {Anita K.} and Tanya Svinkina and Schneider, {Rebekka K.} and Marie McConkey and Marcus J{\"a}r{\aa}s and Elizabeth Griffiths and Meir Wetzler and Lars Bullinger and Cathers, {Brian E.} and Carr, {Steven A.} and Rajesh Chopra and Ebert, {Benjamin L.}",
year = "2015",
month = "7",
day = "9",
doi = "10.1038/nature14610",
language = "English",
volume = "523",
pages = "183--188",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7559",